Evidence map›Paper›PMID 36290968›Full record

ArticleBiosensors2022

A Contact-Free Optical Device for the Detection of Pulmonary Congestion-A Pilot Study.

Ilan Merdler, Aviram Hochstadt, Eihab Ghantous, Lior Lupu, Ariel Borohovitz, David Zahler, Philippe Taieb, Ben Sadeh, Zeev Zalevsky, Javier Garcia-Monreal and 5 more

Abstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ilan MerdlerDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0003-3294-5968
Aviram HochstadtDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0002-9404-3145
Eihab GhantousDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0002-5029-0232
Lior LupuDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0003-4873-2887
Ariel BorohovitzDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.
David ZahlerDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0002-6887-3348
Philippe TaiebDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0003-4287-3371
Ben SadehDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.
Zeev ZalevskyDonisi Health, Formerly Contin Use Biometrics Ltd., Tel Aviv 69978, Israel.
Javier Garcia-MonrealDonisi Health, Formerly Contin Use Biometrics Ltd., Tel Aviv 69978, Israel.
Michael ShergeiDonisi Health, Formerly Contin Use Biometrics Ltd., Tel Aviv 69978, Israel.
Maxim ShatskyDonisi Health, Formerly Contin Use Biometrics Ltd., Tel Aviv 69978, Israel.
Yoav BeckDonisi Health, Formerly Contin Use Biometrics Ltd., Tel Aviv 69978, Israel.
Sagi PolaniDonisi Health, Formerly Contin Use Biometrics Ltd., Tel Aviv 69978, Israel.
Yaron ArbelDepartment of Cardiology, Tel Aviv Medical Center, 6 Weizmann Street, Tel Aviv, Tel-Aviv University, Tel Aviv 69978, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe cost of heart failure hospitalizations in the US alone is over USD 10 billion per year. Over 4 million Americans are hospitalized every year due to heart failure (HF), with a median length of stay of 4 days and an in-hospital mortality rate that exceeds 5%. Hospitalizations of patients with HF can be prevented by early detection of lung congestion. Our study assessed a new contact-free optical medical device used for the early detection of lung congestion.

methodsThe Gili system is an FDA-cleared device used for measuring chest motion vibration data. Lung congestion in the study was assessed clinically and verified via two cardiologists. An algorithm was developed using machine learning techniques, and cross-validation of the findings was performed to estimate the accuracy of the algorithm.

resultsA total of 227 patients were recruited (101 cases vs. 126 controls). The sensitivity and specificity for the device in our study were 0.91 (95% CI: 0.86-0.93) and 0.91 (95% CI: 0.87-0.94), respectively. In all instances, the observed estimates of PPVs and NPVs were at least 0.82 and 0.90, respectively. The accuracy of the algorithm was not affected by different covariates (including respiratory or valvular conditions).

conclusionsThis study demonstrates the efficacy of a contact-free optical device for detecting lung congestion. Further validation of the study results across a larger and precise scale is warranted.

Indexed as

Heart FailureOptical DevicesPulmonary EdemaHumansLungPilot ProjectsUnited Statescameracongestioncontact-freeheart failureincreased lung fluid contentremote monitoring

Identifiers

PMID36290968
PMCPMC9599847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.